Tocilizumab for the Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease in Children: Two Case Reports and Literature Review
Journal of Inflammation Research · 2026-06 · Volume 19 · 1-11
DOI: 10.2147/jir.s603769 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Inflammation Research, 2026-06. Verfasst von Li-E Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Guangxi Clinical Research Center for Pediatric Dise…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Guangxi Clinical Research Center for Pediatric Diseases, Nanning, Guangxi, 530000, People's Republic of China.
ORCID-Profile: Si-Liang Lu
Zitieren
APA
Wu, L. E., Huang, C. L., Wei, J. Y., & Lu, S. L. (2026). Tocilizumab for the Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease in Children: Two Case Reports and Literature Review. Journal of Inflammation Research, Volume 19, 1-11. https://doi.org/10.2147/jir.s603769
Vancouver
Wu LE, Huang CL, Wei JY, Lu SL. Tocilizumab for the Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease in Children: Two Case Reports and Literature Review. Journal of Inflammation Research. 2026;Volume 19:1-11. doi:10.2147/jir.s603769
BibTeX
@article{Wu2026,
author = {Wu, Li-E and Huang, Chun-Lin and Wei, Jun-Yu and Lu, Si-Liang},
title = {Tocilizumab for the Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease in Children: Two Case Reports and Literature Review},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--11},
doi = {10.2147/jir.s603769}
}
EUVIMED